The Saccharomyces cerevisiae piD261/Bud32 protein and its structural homologues, which are present along the ArchaeaEukarya lineage, constitute a novel protein kinase family (the piD261 family) distantly related in sequence to the eukaryotic protein kinase superfamily. It has been demonstrated that the yeast protein displays Ser/Thr phosphotransferase activity in vitro and contains all the invariant residues of the family. This novel protein kinase appears to play an important cellular role as deletion in yeast of the gene encoding piD261/Bud32 results in the alteration of fundamental processes such as cell growth and sporulation. In this work we show that the phosphotransferase activity of Bud32 is relevant to its functionality in vivo, but is not the unique role of the protein, since mutants which have lost catalytic activity but not native conformation can partially complement the disruption of the gene encoding piD261/Bud32. A two-hybrid approach has led to the identification of several proteins interacting with Bud32; in particular a glutaredoxin (Grx4), a putative glycoprotease (Ykr038/Kae1) and proteins of the Imd (inosine monophosphate dehydrogenase) family seem most plausible interactors. We further demonstrate that Grx4 directly interacts with Bud32 and that it is phosphorylated in vitro by Bud32 at Ser-134. The functional significance of the interaction between Bud32 and the putative protease Ykr038/Kae1 is supported by its evolutionary conservation.
The Saccharomyces cerevisiae piD261/Bud32 protein and its structural homologues, which are present along the ArchaeaEukarya lineage, constitute a novel protein kinase family (the piD261 family) distantly related in sequence to the eukaryotic protein kinase superfamily. It has been demonstrated that the yeast protein displays Ser/Thr phosphotransferase activity in vitro and contains all the invariant residues of the family. This novel protein kinase appears to play an important cellular role as deletion in yeast of the gene encoding piD261/Bud32 results in the alteration of fundamental processes such as cell growth and sporulation. In this work we show that the phosphotransferase activity of Bud32 is relevant to its functionality in vivo, but is not the unique role of the protein, since mutants which have lost catalytic activity but not native conformation can partially complement the disruption of the gene encoding piD261/Bud32. A two-hybrid approach has led to the identification of several proteins interacting with Bud32; in particular a glutaredoxin (Grx4), a putative glycoprotease (Ykr038/Kae1) and proteins of the Imd (inosine monophosphate dehydrogenase) family seem most plausible interactors. We further demonstrate that Grx4 directly interacts with Bud32 and that it is phosphorylated in vitro by Bud32 at Ser-134. The functional significance of the interaction between Bud32 and the putative protease Ykr038/Kae1 is supported by its evolutionary conservation.
INTRODUCTION
Sequence analysis of the genomes of several prokaryotic and eukaryotic organisms has disclosed a number of putative protein kinase families that are distantly related in sequence to the eukaryotic protein serine/threonine kinase superfamily and that are present in both prokaryotes and eukaryotes [1] . To one of these, the piD261 family, belongs the product of the Saccharomyces cerevisiae YGR262c/BUD32 gene, piD261/Bud32, [2] and its structural homologues, that are present in virtually all eukaryotes and in archaebacteria, but not in eubacteria.
The relevant features of the piD261/Bud32 protein are the small size (261 residues), its low similarity with the other members of the eukaryotic protein kinase family and the alteration of some of the motifs highly conserved in the family.
Despite these structural abnormalities piD261/Bud32, expressed in Escherichia coli as a recombinant protein, acts in vitro as a Ser/Thr protein kinase, recognizing acidic substrates and depending on Mn 2+ , instead of Mg 2+ , for catalysis [3, 4] . A recent mutational analysis has demonstrated that, despite the low overall similarity, the invariant residues representing the signature of protein kinases are in fact conserved in piD261/Bud32, but are embedded in an altered context, suggestive of unique mechanistic properties [5] . All the main structural features of piD261/Bud32 are conserved in the homologous proteins present in higher eukaryotes, notably the human one, suggesting that they underlie common biological function(s) in distantly related organisms.
Abbreviations used: PRPK, p53-related protein kinase; IMD, inosine monophosphate dehydrogenase; Grx, glutaredoxin; PKA, cAMP-dependent protein kinase; GFP, green fluorescent protein; Gal4 BD, Gal4 DNA-binding domain; Gal4 AD, Gal4 transcriptional activation domain; SPR, surface plasmon resonance; HA, haemagglutinin; MALDI, matrix-assisted laser-desorption ionization. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (e-mail giovanna.carignani@unipd.it).
The biological functions of piD261/Bud32 and of the other members of the family are unknown; they must be crucial for key cellular processes, however, since deletion of the yeast YGR262c/ BUD32 gene dramatically inhibits mitotic growth, resulting in a severe slow-growth phenotype [6] . Homozygous diploid mutants are unable to enter sporulation, with no visible meiotic division [7] . Accordingly, results of yeast transcriptome analysis [8] indicate an enhancement of YGR262c/BUD32 transcription during sporulation. Mutant cells also display morphogenetic defects, notably alterations in cell-wall structure [9] and budding [10] . Due to the latter phenotype the name BUD32 has been attributed to the YGR262c gene.
The human structural homologue of Bud32, named PRPK (p53-related protein kinase), has proved to be a functional homologue of the yeast protein, as it partially complements the phenotype resulting from deletion of the yeast YGR262c/BUD32 gene [11] . PRPK must also be implicated in cell proliferation, as it is able to bind to p53 and to phosphorylate it at Ser-15, a key event for cell-cycle arrest due to genotoxic conditions [12] . Interestingly, PRPK mRNA is markedly expressed, among normal human tissues, only in testis, while its expression is considerably elevated in interleukin-2-activated cytotoxic T-cells and in some human epithelial tumour cell lines [12] .
These observations prompted us to start an investigation aimed at assessing the functional relevance of Bud32 phosphotransferase activity in the cell and disclosing its targets and partners in yeast. Here we show that the phosphotransferase activity of the Bud32 protein is relevant to its functionality in vivo, but also that the protein must have a more complex role in the cell. By the twohybrid approach we have identified several Bud32-interacting proteins, among which a putative glycoprotease, Ykr038 the Grx4 glutaredoxin and proteins encoded by the IMD (inosine monophosphate dehydrogenase) gene family appear to be most probable interactors. The demonstration that Grx4 is phosphorylated by Bud32 in vitro strongly suggests that the cellular activity of Grx4 might be modulated by the Bud32 protein kinase.
EXPERIMENTAL

Strains and media
Yeast strains were as follows: W303-1B (Mat a; ade2-1 ) gal dcm (DE3)]. The following media were used: YPD (1 % yeast extract/1 % bactopeptone/2 % dextrose); SD (0.67 % yeast nitrogen base without amino acids/2 % dextrose/auxotrophic requirements as needed); adenine-limiting (SD medium with 10 mg/l adenine); sporulation (1 % potassium acetate); and Luria-Bertani (1 % Bactotryptone/0.5 % yeast extract/0.5 % NaCl; when requested, ampicillin was added to a final concentration of 100 µg/ml). Solid media were obtained by the addition of 2 % agar. Media components were from Difco, and amino acids were from Sigma.
Phenotype-complementation assay
The pFL-261 plasmid contains the BUD32 coding sequence under the control of the BUD32 promoter. The sequence has been obtained by amplification of the S. cerevisiae chromosomal region comprising the BUD32 coding sequence surrounded by 723 bp upstream and 189 bp downstream, using the primers 5 -PROM (5 -CTGCTGGATCCAATGCTGTTTTG-3 ) and 3 -PROM (5 -GTTTGCTGCAGTTGGTTTACC-3 ), which introduce the restriction sites BamHI and PstI respectively (underlined). The resulting amplification product was cloned into the centromeric pFL-38 vector [13] at the BamHI/PstI sites.
The same insert was also cloned into the BamHI/PstI sites of plasmid pASZ11 [14] to obtain the BUD32-pASZ11 vector. This is a yeast centromeric plasmid carrying the ADE2 gene as a selectable marker. After transformation of an ade2 mutant strain, the colonies formed by yeast cells containing the plasmid are white and can be isolated by growth on selective medium lacking adenine. Subsequent growth of these cells on an adenine-limiting medium determines a spontaneous loss of plasmid that can be easily monitored by the colour change of the colonies, which become red. The use of this plasmid is particularly useful because it allows the maintenance of an extra-chromosomal copy of one gene in the yeast cell, but also, when necessary, it allows us to obtain the loss of this gene copy by a simple shift in the appropriate medium followed by a colour-monitoring of the growing colonies. This plasmid was used to transform a +/ BUD32 heterozygous diploid yeast strain and, after tetrad dissection of transformed diploids, to isolate BUD32 haploid cells carrying the extra-chromosomal copy of the BUD32 gene, giving the 'protected' W303-1B BUD32 haploid yeast strain used for the complementation assays.
Mutagenesis of the BUD32 gene
The mutant forms of the BUD32 gene were obtained using the QuikChange TM Site-Directed Mutagenesis Kit (Stratagene; catalogue no. 200518). The mutagenic primers were designed according to the instruction manual. As double-stranded DNA templates we used the plasmidic construct pFL-261 described above.
Tetrad dissection
The W303-1B +/ BUD32 heterozygous diploids transformed with the pFL-261 plasmid (or the pFL-261 plasmid carrying a mutated BUD32 coding sequence) were allowed to sporulate on 1 % potassium acetate solid medium for 4-6 days at 25
• C. About 15 tetrads/diploid transformant strain were dissected and the spores allowed to germinate on YPD medium at 28
• C. For each spore, the geneticin-resistant phenotype (indicating the presence of the BUD32 allele) and the presence of the pFL-261 plasmid were controlled by growth on selective media.
Two-hybrid screening
The entire 783 bp BUD32 open reading frame was amplified by PCR from yeast genomic DNA using appropriate primers, 5 -BAIT (5 -CGCTTTGGATCCTTATGACGCAAGAA-3 ) and 3 -BAIT (5 -GGAATTCCTGCAGGGTACCC-3 ), containing the BamHI and PstI recognition sequences respectively (underlined). The resulting amplified fragment, digested with BamHI and PstI, was cloned in frame to the Gal4 BD (Gal4 DNA-binding domain) coding sequence in vector pGBT9 (Clontech), previously digested with the same two enzymes. The resulting plasmid, pGBT9-Bud32, encodes the fusion protein Gal4 BD-Bud32. This retains the physiological function of Bud32, as the yeast BUD32 strain transformed with the pGBT9-Bud32 plasmid showed complete recovery of the wild-type phenotype. The bait pGBT9-Bud32 plasmid was used to transform the reporter S. cerevisiae strain Y190 (Clontech). The resulting strain was transformed using a high-efficiency lithium acetate transformation method [15] , with a yeast chromosomal DNA library fused to the Gal4 AD (Gal4 transcriptional activation domain) and to the influenza HA (haemagglutinin) epitope. The library (FRYL) was kindly provided by M. Fromont-Racine and P. Legrain (Institut Pasteur, Paris, France) [16] . Transformants containing both bait and library plasmids and able to activate transcription of the HIS3 reporter gene were selected for growth on selective minimal medium lacking leucine, tryptophan, histidine and containing 60 mM 3-AT (3-amino-1,2,4-triazole; Sigma). Next, these first-screening positive clones were tested for the activation of the second reporter gene (lacZ) by their ability to generate blue colonies in the presence of X-gal. Library plasmids were extracted from positive yeast clones and separated from bait plasmids by transformation of the MC1066 E. coli strain [17] . These candidate plasmids were reintroduced into the Y190 yeast strain together with the original bait plasmid pGBT9-Bud32, or the pGBT9 plasmid alone, in order to confirm the interaction. The inserts of the plasmids that overcame these selective steps were sequenced and their identity determined by database searching: the exact position of the fusion with GAL4 was identified for each prey by sequencing the 5 -end of the insert; sequencing of the 3 -end was necessary only for inserts longer than 700-800 bp.
Expression of His-tagged recombinant proteins
The plasmid pET-261 [3] was used to express the C-terminal His 6 -tagged Bud32 recombinant protein in E. coli cells. The protocol steps for protein purification are described elsewhere [5] .
The coding sequence of the GRX4 gene was amplified by PCR from yeast genomic DNA using primers 5 -GRX4 (5 -TCCCGGGTCATATGTTATGACTGTGG-3 ) and 3 -GRX4 (5 -AGGCTCGAGCTGTAGAGCATGTTGG-3 ) that introduced the restriction sites for NdeI and XhoI (underlined): the PCR product was cloned into the pET-20b(+) plasmid (Novagen) digested with the same enzymes, giving the pET-Grx4 expression vector. For the purification of Grx4-His 6 , the E. coli strain BL21(DE3), transformed with plasmid pET-Grx4, was grown in Luria-Bertani medium at 37
• C until the D 600 value reached 0.7-0.8, when transcription of the GRX4 coding sequence was induced with 0.4 mM isopropyl β-D-thiogalactoside (Calbiochem). After 16-20 h of incubation at 16
• C bacteria were harvested and resuspended in 5 ml/g of pellet of purification buffer (0.02 M Tris/HCl, pH 7.5, 0.3 M NaCl, 10 % glycerol and 0.2 mM PMSF) in the presence of a protease inhibitor cocktail (Boehringer Mannheim). Purification was performed according to the protocol of the manufacturer by an affinity column containing Ni 2+ -nitrilotriacetate-agarose (Qiagen). The 27 kDa Grx4-His 6 was eluted with 0.04 M imidazole. All protein concentrations were determined by the method of Bradford [18] using BSA as a standard.
Immunoprecipitation and immunoblotting
Yeast cells transformed with the appropriate plasmid were grown in 100 ml of selective medium until mid-log phase (approx. • C) and the protein concentration of the soluble fraction was determined by the Bradford method. The soluble fraction was divided into aliquots of 6 mg of total proteins and a pre-cleaning of the solution was performed with Protein-A-Sepharose (Sigma), saturated with BSA and equilibrated with breaking buffer, to reduce non-specific binding. Samples were then incubated with anti-HA antibodies (Boehringer Mannheim) at 4
• C for 2 h. The immunocomplexes were precipitated with Protein-A-Sepharose; the pellets were washed three times with PBS, blocked in a buffer consisting of 0.6 M Tris/HCl, pH 6.8, 2 % SDS, 20 % glycerol and 0.005 M β-mercaptoethanol and subjected to SDS/PAGE (11 % gels). The proteins were blotted on to PVDF membrane (Millipore) and detected using mouse antiserum against Bud32-His 6 as described in [5] , or monoclonal anti-HA antibodies (Boehringer Mannheim).
SPR (surface plasmon resonance) analysis
For the SPR analysis, a BIAcoreX system was used, as described in [19] , with the following modifications. Recombinant Bud32 was covalently immobilized on the surface of a flow cell in a CM5 sensor chip, to a final density of 2600 resonance units, while a flow cell with no immobilized protein was used as a control. The interacting protein solutions of Grx4 were injected at a flow rate of 10 µl/min, and each sensorgram (time course of the SPR signal) was corrected for the response obtained in the control flow cell. Surface was regenerated by injection of 0.01 M NaOH, with a contact time of 1 min. The kinetic data were interpreted with a simple 1:1 binding model, and the rate constants of the interactions were calculated by using the BIAevaluation 3.0 SPR kinetic software (BIAcore). The reported values are the means from three separate experiments, with S.E.M. values lower than 10 %.
Phosphotransferase assay
The protein kinase activity of Bud32 was assayed as described elsewhere [5] by incubating the recombinant His-tagged protein (0.3 µM final concentration) at 37
• C for 15 min in 20 µl of medium containing 0.05 M Tris/HCl, pH 7.5, 0.01 M MnCl 2 and 25 µM [γ -
32 P]ATP (Amersham Biosciences; specific radioactivity, 2000-3000 c.p.m./pmol) and the Grx4 protein (0.9-1.8 µM final concentration) as phosphorylatable substrate. The reaction was stopped by adding the gel electrophoresis loading buffer and samples were subjected to SDS/PAGE (11 % gels). The dried gels were scanned directly using the Cyclone apparatus (Packard).
Fluorescence analysis
In order to determine the subcellular localization of both the Bud32 and Grx4 proteins, we expressed them as fusion proteins to the C-terminus of the GFP (green fluorescent protein). The coding sequence of the BUD32 and GRX4 genes were amplified from yeast genomic DNA by PCR using the primers 5 -GFP-BUD32 (5 -CCGGATCCATGACGCAAGAATTCATTG-3 ) and 3 -GFP-BUD32 (5 -ACTCGAGTTATCCTAGCATACTTCTCTTAC-3 ) for the BUD32 gene and 5 -GFP-GRX4 (5 -CGGATCCATG-ATGAGTTCGAGAGTAACC-3 ) and 3 -GFP-GRX4 (5 -GCTC-GAGATTACTGTAGAGCATGTTG-3 ) for the GRX4 gene, carrying the restriction sites for BamHI and XhoI (underlined): the amplification products were cloned into the pUG-36 plasmid [20] , digested with the same enzymes, downstream of the GFP coding sequence. The conservation of the correct reading frame of the fusion was verified by sequencing. To ascertain whether the GFP-Bud32 fusion protein maintains its functionality, yeast cells carrying the inactivation of the BUD32 gene were transformed with the Bud32-pUG-36 plasmid and it could be observed that the fusion protein fully complemented the slow-growth phenotype. Yeast cells were transformed with Bud32-pUG-36 or Grx4-pUG-36 and the fluorescence analysis was performed using an Olympus IMT-2 microscope. Fluorescence analysis and preparation of samples were performed according to [20] . Image analysis was performed using Metamorph software (Universal Imaging, Downingtown, PA, U.S.A.).
MS analysis
MALDI (matrix-assisted laser-desorption ionization) analysis was carried out using a MALDI-Tof (Micromass) on the tryptic digest before and after treating the sample with Ba(OH) 2 . The reaction with Ba(OH) 2 implies a β-elimination of H 3 PO 4 and the generation of dehydrated serine (or threonine) at the site of phosphorylation [21] [22] [23] .
Tryptic digestion of Grx4
The gel bands containing phosphorylated Grx4 were excised and subjected to reduction, alkylation and tryptic digestion according to [24] . Briefly, Coomassie-stained bands were excised, dehydrated with acetonitrile, reduced with 0.01 M dithiothreitol for 1 h at 56
• C and then carboxyamidomethylated with 0.055 M iodacetamide in the dark for 45 min. The gel pieces were dehydrated with acetonitrile and rehydrated with 0.05 M ammonium bicarbonate containing 12.5 ng/µl trypsin. After overnight digestion at 37
• C, the peptides were extracted by washing the gel pieces three times with 50 % acetonitrile/5 % formic acid. The solution was concentrated in Speed Vac and then desalted using a C 18 Zip-Tip (Millipore).
Chemical dephosphorylation of the peptides
Digested protein (1 µl) was mixed with 1 µl of matrix [5 mg/ml α-cyano-4-hydroxycinnamic acid (Aldrich) in 50 % acetonitrile/ 0.1 % formic acid] and spotted on to the target plate. The sample was treated with a saturated solution of Ba(OH) 2 for 20 min and was desalted using a C 18 Zip-Tip (Millipore), mixed with the matrix and spotted on to the target plate. The spectra were inspected manually and compared to identify probable phosphopeptides subjected to chemical dephosphorylation. The identification of the phosphorylation sites was made by acquiring MS/ MS spectra of the chemically dephosphorylated peptides using an Ultima Q-Tof (Micromass). The spectra were interpreted manually according to [25] and the phosphorylation sites identified unequivocally.
RESULTS AND DISCUSSION
Cellular function of Bud32 does not exclusively rely on its phosphotransferase activity
Deletion in S. cerevisiae of the YGR262c/BUD32 gene, encoding piD261/Bud32, confers to mutant strains a pleiotropic phenotype resulting in a very slow vegetative growth of colonies. This phenotype is complemented by ectopic expression of the wild-type BUD32 sequence [6] . To establish whether and to what extent the functionality of the Bud32 protein in vivo relies on its phosphotransferase activity, the complementation of the slow-growth phenotype by the Bud32 wild-type protein was compared with that obtained with mutants shown previously in vitro to be severely defective in catalytic activity [5] . These are mutants G25V (in which the only residual Gly of the glycine loop is substituted by Val), K52A [in which the lysine corresponding to K72 of PKA (cAMP-dependent protein kinase) is substituted by Ala] and D161A (in which the aspartic acid corresponding to the catalytic base, Asp-166, of PKA is substituted by an Ala residue). As shown in Figure 1 , the three mutated BUD32 sequences, inserted in a centromeric plasmid under the control of the BUD32 gene promoter, were not able to fully restore the wild-type growth phenotype of BUD32 cells as did the wildtype BUD32 sequence inserted in the same plasmid. In particular the effect is observed on the growth of spores issued from the dissection of a heterozygous diploid +/ BUD32 transformed with the different plasmids ( Figure 1 , top panels; compare the sizes of colonies formed by BUD32 spores in the presence of the mutant alleles and those of BUD32 spores in the presence of the wild-type allele). However, when the same segregants are replated, their colonies grow at rates very similar to the wild-type. Accordingly, when haploid vegetative BUD32 cells are transformed with plasmids carrying the mutant alleles, com- plementation of the phenotype is lower than that observed with the wild-type allele, but the difference is slight (Figure 1, lower  panel) . In this case, BUD32 cells were 'protected' and the phenotype due to complementation was observed after loss of the BUD32-pASZ11 plasmid (see the Experimental section). This result suggests that mutations in Bud32 residues that have an essential role in the phosphotransferase reaction, but are not expected to alter the overall conformation of the protein, mainly cause a defect in the spore germination processes. This effect has been observed only in the case of 'catalytic' mutations in the Bud32 protein kinase, while other Bud32 mutations (e.g. K57A), which do not alter its in vitro catalytic activity [5] , behave as the wild-type. Since post-germination growth defects have been observed in several cases of mutations in genes involved in the biogenesis and integrity of the cell wall [26] [27] [28] , and YGR262c/BUD32 has been classified as a cell-wall-related gene [9] , it is possible that the result is due to a difficulty of the mutants to modify the spore wall, a process necessary to permit spore outgrowth and formation of the initial bud. These results allow us to establish a correlation between the biological competence of Bud32 and its phosphotransferase activity. However, they also show that the presence of Bud32, even in a catalytically inactive form, is able to significantly rescue the severe phenotype of the BUD32 mutant. Without completely excluding the possibility that, in the presence of the cellular context, the partial complementation of the phenotype is due to a more than physiological concentration of the mutant proteins (owing to the potential presence of more than one single copy of the centromeric plasmid) resulting in an overall significant, albeit low, catalytic activity, this result suggests that, in addition to its protein kinase activity, the Bud32 protein might have other cellular roles. One possibility would be that the presence of the Bud32 protein, whether devoid of catalytic activity or not, allows the establishment of functional interactions with other proteins, whose activity is normally regulated by the Bud32 protein, leading to a partial suppression of the BUD32 phenotype. This prompted us to search the yeast genome for genes expressing proteins able to interact with Bud32.
Identification of cellular partners of Bud32 by the Gal4-based two-hybrid system
Using Bud32 as a 'bait' (Gal4 BD-Bud32) we have screened a yeast genomic expression library to search for polypeptides (Gal4 AD-Preys) able to interact with Bud32. We obtained approx. 3 × 10 6 independent transformants, 89 of which were positive to the first reporter gene HIS3. Of these, 24 clones were positive also to the second reporter gene, lacZ. After confirmation of the interaction with Bud32 for all the polypeptides expressed by the positive plasmids, the inserts were identified by DNA sequencing. As it can be seen in Table 1 , the inserts of the isolated 24 clones represent different fragments of the yeast genome that identify 11 different genes. In several cases, only one fragment represents a given gene, while four genes (GRX4, YKR038c, IMD1, IMD2) are identified by more than one fragment. In addition, two clones contain fragments of genes GRX3 and IMD4, which are highly homologous respectively to GRX4 and IMD1/IMD2. On the basis of the number of different fusions recovered from the same prey protein we conclude that Grx4, Ykr038 and proteins encoded by the IMD gene family are the most plausible interactors of Bud32. We focused our attention on Grx4, which has been identified unambiguously by several clones (9/24 clones), and tried to confirm its interaction with Bud32 using alternative approaches.
However, the interactions of Bud32 with Ykr038 and the Imd proteins also seem interesting and merit further study. IMP dehydrogenases are the rate-limiting enzymes in the de novo synthesis of guanine nucleotides and appear to play a crucial role in the growth of many cell types (see [29] for a review), including yeast [30] . The putative association with these proteins might be related to the proposed involvement of Bud32 in the control of cellular proliferation, indicated by the slow-growth phenotype due to YGR262/BUD32 deletion [6] . As regards Ykr038, though a functional characterization of the protein is lacking, its significant sequence similarity with a O-sialo-glycoprotease characterized from Pasteurella haemolytica [31] suggests that the protein, whose primary structure appears to be conserved all along the evolutionary timescale, might be endowed with proteolytic activity. In S. cerevisiae the integrity of the YKR038c gene is essential for cell life, as its inactivation is lethal ( [32] , and R. Lopreiato and G. Sartori, unpublished work). The functional significance of the Bud32-Ykr038 association, identified by our two-hybrid system, is highlighted by the observation that in some species of Methanococcus (Archaea), a single gene encodes a polypeptide formed by an N-terminal region similar to the Ykr038 protein and a C-terminal region similar to the Bud32 protein kinase (Figure 2 ). Thus the interaction observed in yeast between the two proteins suggests an evolutionary mechanism of separation of the genes and conservation of the functional interaction between the two gene products. In accordance with these observations, we have reserved at Saccharomyces Genome Database (http://www.yeastgenome.org/) the name KAE1 (kinaseassociated endopeptidase 1) for the YKR038c gene.
Grx4 interacts directly with Bud32 and is phosphorylated by it at Ser-134
The Grx4 protein is a member of the Grx superfamily, involved in maintaining the redox state of cellular proteins and comprising mainly thiol-disulphide oxidoreductases. Grx4 belongs to a subfamily of yeast Grxs (Grx3, Grx4 and Grx5) that contain a single cysteine residue at the active site. This trait is also characteristic of a number of Grxs from bacteria to humans, with which the Grx3/4/5 group shares extensive homology over two regions. While the role of Grx5 has been in part clarified, no evidence yet has been provided for the specific roles of Grx3 and Grx4 [33, 34] . Thiol-disulphide oxidoreductases have often been found associated with protein kinases and phosphatases in mammals, where they are believed to regulate the activity of these enzymes in response to redox signals [35] [36] [37] .
Bud32 and Grx4 interact directly
The interaction between Bud32 and Grx4 was confirmed by a number of different techniques. The first was by a reciprocal two-hybrid assay, which showed that reconstitution of the Gal4 activator occurs also when the Grx4 protein is fused to Gal4 BD and the Bud32 protein to Gal4 AD.
The second technique was by co-immunoprecipitation, taking advantage of wild-type yeast cells transformed with one of the Bud32-interacting plasmids that express a fusion protein Gal4 AD-HA epitope-Grx4, which was then immunoprecipitated from cell lysates with commercial anti-HA antibodies. After analysis by SDS/PAGE and Western blot it could be observed that immunoprecipitation of Grx4 by the anti-HA antibody (Figure 3B, lane 4) induces the co-precipitation of Bud32 (recognized by anti-Bud32 antibodies) as well ( Figure 3A, lane 4) . The third technique was by SPR analysis: recombinant Bud32 purified from E. coli was covalently immobilized on the BIAcore Sensor Chip and a solution containing the Grx4 recombinant protein at different concentrations was allowed to flow over the chip. The resulting sensorgram shows that Bud32 and Grx4 are able to interact (Figure 4) , so definitely providing the demonstration that the interaction between the two proteins is direct. The SPR analysis also allows estimation of the kinetic parameters of the interaction between the two proteins (K D = 8.88 × 10 −6 M). The interaction was confirmed in a reciprocal experiment in which the Grx4 protein was immobilized on the BIAcore Sensor Chip and a Bud32 solution was allowed to flow over it (results not shown).
Fourth, it should be mentioned that Grx4 was identified in protein complexes with Bud32 by an independent study based on high-throughput MS analysis [38] .
Domains implicated in the interaction
Based on the two-hybrid results, the interaction between Bud32 and Grx4 appears to be mediated by the C-terminal region of Grx4, given the presence of this region in all the interacting clones identified by the two-hybrid approach and, in particular, the presence in one of the clones of only the last 100 amino acids (containing the catalytic CGFS site).
In order to map the region of Bud32 involved in the interaction, we prepared three different truncated forms of the Bud32 protein fused to the Gal4 BD domain (expressing amino acids 1-86, 1-196 and 87-STOP of Bud32) and used them in two-hybrid experiments to ascertain if they were still able to interact with the Grx4 protein (expressed by one of the Gal4 AD fusion plasmids). None of the truncated forms of Bud32 was able to interact, suggesting that either the overall 3D conformation is required or that the truncated peptides were unstable.
Bud32 phosphorylates Grx4 in vitro
We have tested the ability of the Bud32 protein kinase to phosphorylate Grx4, using the two recombinant proteins expressed and purified from E. coli in a phosphotransferase in vitro assay. As shown in Figure 5 , Grx4 is phosphorylated in the presence of the wild-type form of Bud32 and not in the presence of a catalytically inactive Bud32 mutant, D161A [5] , thus demonstrating the specificity of the phosphotransferase reaction. Phosphorylation linearly reaches 0.01-0.02 mol of phosphate/mol of Grx4 after 15 min of incubation, but it can be increased significantly by prolonging incubation and adding fresh aliquots of Bud32 at regular times: after three successive additions of Bud32 and 90 min incubation a stoichiometry of 0.15 mol of phosphate/mol of Grx4 has been observed. The kinetic parameters of the reaction have been calculated also (see Figure 6 and insets therein). While the submicromolar K m value is consistent with the physiological relevance of Grx4 phosphorylation by Bud32, the V max value corroborates the view that the catalytic efficiency of Bud32 is extremely low. Indeed the k cat values of Bud32, determined with peptide substrates [4, 5] , are 4-5 orders of magnitude lower than those displayed in comparable assays by typical protein kinases, notably PKA and protein kinase CKII, probably owing to a number of abnormal features in the catalytic core of Bud32, as discussed elsewhere [5] . Especially remarkable in this respect is the poor conservation of the catalytic loop, where an essential lysyl residue conserved in all Ser/Thr protein kinases (Lys-168 in PKA), responsible for the transfer of the γ phosphate of ATP to the phosphoacceptor residue, is replaced by threonine (Thr-163) [5] . Mutation of PKA Lys-168 to alanine results in a 99.7 % drop in catalytic efficiency [39] , whereas mutation of Bud32 Thr-163 to alanine has no effect [5] . It can be concluded therefore that the alteration of the catalytic loop, with special reference to the lack of the essential lysine, is largely responsible for the low catalytic activity of Bud32. Whether such a low phosphotransferase activity reflects the fact that it is not crucially required for the physiological role of Bud32 remains an open question. The observation, reported above, that mutants which have almost completely lost catalytic activity are nevertheless able to partially complement the lack of Bud32 (see Figure 1) may argue in favour of this hypothesis. On the other hand the same experiments clearly show that complementation by these defective mutants is only partial, as compared with the wild type, consistent with a still important physiological role of Bud32 phosphotransferase activity.
In order to identify the residues phosphorylated by Bud32, phosphorylated Grx4 was digested with trypsin and the resulting peptides analysed by MALDI-time-of-flight MS. An aliquot of the tryptic digest was chemically phosphorylated by Ba(OH) 2 . A comparison between the spectrum obtained with the tryptic peptides before and after chemical dephosphorylation (Figure 7 , top panel) allowed us to identify one chemically dephosphorylated peptide corresponding to residues 124-148 (STSDEESSGSSDD-EEDETEEEINAR). The peptide contains six serines and two threonines, all possible targets of phosphorylation by Bud32. Further analysis by electrospray ionization-tandem MS of the chemically dephosphorylated peptides showed that the main target of Bud32 is Ser-134 (underlined above; Figure 7 , bottom panel). A very weak phosphorylation of other seryl residue(s) in the same peptide has been also observed. Among these, Ser-133 has been identified as responsible, together with Ser-134, for the presence of a minimal amount of a bis-phosphorylated form of the 124-148 peptide. Note that the presence of several glutamic and aspartic acid residues surrounding Ser-134/Ser-133 corroborates the concept that Bud32 is an acidophilic Ser/Thr protein kinase [4] . Since the MALDI analysis showed a percentage of coverage of protein which is about 90 %, we cannot exclude that the Bud32 protein kinase could phosphorylate different regions of Grx4 as well, but our data strongly indicate Ser-134 as the main phosphorylation site.
The location of the Ser-134 residue outside the C-terminal region of Grx4, responsible for association with Bud32 in the two-hybrid analysis (downstream from residue 148; see Table 1 ), supports the view that physical interaction with and phosphorylation by Bud32 are separate events, a conclusion reinforced by the significantly different values of the K m for the phosphotransferase reaction (0.34 µM) and the K d value calculated from the BIAcore analysis (8.8 µM) . Note that a similar behaviour has been recently reported in the case of p53 phosphorylation by and interaction with Bud32 [11] . Associations between thiol-disulphide oxidoreductases and protein kinases have been observed in mammals [35, 36] and a notable example is the association between human protein kinase Cθ and the putative oxidoreductase PICOT (protein kinase C-interacting cousin of thioredoxin), which is structurally similar to Grx4. However, in this case no phosphorylation of PICOT by protein kinase C could be observed [37] . Phosphorylation of proteins of the thiol-disulphide oxidoreductase family has been reported already, e.g. the phosphorylation of a 57 kDa rat protein (p57) related to protein disulphide isomerase by the Lyn tyrosine kinase is required for its association with the SH2 domain of the kinase [40] .
Subcellular localization of the Bud32 and Grx4 proteins
In order to define the cellular localization of the two interacting proteins Bud32 and Grx4 both were expressed as green fluorescent fusion proteins. The fused GFP-BUD32 sequence, expressing the Bud32 protein fused to the C-terminus of GFP, was placed on a yeast expression plasmid under the control of the methioninerepressible MET25 promoter [20] . Wild-type and BUD32 yeast cells were transformed with GFP-Bud32 or GFP alone and observed at the microscope for GFP signals. In contrast to the cytoplasmic localization of the GFP alone, the majority of cells expressing GFP-Bud32 showed a strong fluorescence which was not detected. The lower spectrum shows the situation after treatment of the tryptic digest with Ba(OH) 2 . A new signal corresponding to chemically dephosphorylated 124-148 peptide is now evident (molecular mass 2729.3 Da). Bottom panel: product ion spectrum of the doubly charged, chemically dephosphorylated peptide Grx4 124-148. A complete y-series allowed the identification of Ser-134 as the main phosphorylation site. The signal at 1763.59 Da (#y 15 ) clearly indicates that Ser-134 was subjected to dephosphorylation under basic conditions. The diagnostic peaks due to the possible dephosphorylation of other Thr or Ser residues within the same peptide are either not present or very weak.
co-localizes with the chromosomal DNA visualized by DAPI (4 ,6-diamidino-2-phenylindole-dihydrochloride; Figure 8 ). This indicates that the fusion protein GFP-Bud32 is mainly located in the nuclear compartment of the cell. No differences in the fluorescence patterns were observed if the fusion protein was expressed at a low level (in the presence of methionine) or overexpressed, nor if the endogenous Bud32 protein was present or not (results not shown). Figure 8 shows that also the GFPGrx4 fusion protein, similarly to GFP-Bud32, predominantly localizes to the nucleus, in agreement with the two-hybrid results that indicate the interaction between the two proteins. It is an interesting reminder that the human homologue of Bud32, PRPK, has also been shown to localize in the nucleus, and this has been correlated with the presence of a nuclear localization signal in the PRPK protein [12] . In Bud32, however, a similar sequence is not present, and a GFP fusion with a truncated Bud32 protein,
Figure 8 Nuclear localization of Bud32 and Grx4
Yeast cells of wild-type strain were transformed with the Bud32-pUG36 or Grx4-pUG36 plasmids and grown on selective medium. Samples harvested from liquid cultures of exponentially growing transformed cells have been observed by fluorescence microscopy to detect the GFP and DAPI (4 ,6-diamidino-2-phenylindole-dihydrochloride) fluorescence signals.
lacking a C-terminal basic stretch, which could also represent a nuclear localization signal, still localizes to the nucleus (results not shown). Thus the structural basis for the nuclear localization of Bud32 remains unclear.
Conclusions
In this work we provide evidence that the phosphotransferase activity of the S. cerevisiae atypical protein kinase piD261/Bud32, previously demonstrated in vitro [3, 5] , is relevant to the function of the protein in vivo, as judged from the functional complementation assays using catalytically inactive mutants of piD261/Bud32. The result points out that, in addition to its protein kinase activity, piD261/Bud32 may have other cellular roles, probably correlated to its ability of interaction with other proteins. The relevance of Bud32 as an interacting protein in yeast was corroborated by the outcome of the two-hybrid approach, that has in fact identified several proteins able to associate with Bud32; in particular a Grx (Grx4), a putative glycoprotease (Ykr038/Kae1) and two proteins encoded by the IMD gene family seem most plausible interactors. All of them were also found, by an independent approach [38] , among a group of about 30 proteins that co-precipitate with Bud32. In this work, we concentrated on Grx4. This protein has been shown by different methods to directly interact with piD261/Bud32 both in vitro and in vivo. We have also obtained evidence that Grx4 is phosphorylated by Bud32 in vitro with a K m value denoting high affinity and we identified Ser-134 as the main phosphorylation site. This is present in a highly acidic stretch, in agreement with the previous characterization of Bud32 as an acidophilic protein kinase [4] . The location of the phosphorylation site upstream from the C-terminal minimal region sufficient for interaction with Bud32 (amino acids 148-STOP) supports the idea that physical interaction with and phosphorylation by Bud32 are distinct events, thus enforcing the relevance of the interaction properties for the Bud32 cellular function(s). The observed biochemical relationship between Bud32 and Grx4 strongly suggests that Grx4 might be one of the physiological targets of Bud32, and points to a possible role of this kinase in the control of the redox state maintenance, by acting as a regulator of Grx4 activity. The phosphorylation of Grx4 by Bud32 is also in agreement with the observed localization of both Bud32 and Grx4 in the nucleus, and points to a concerted role of the two proteins in this compartment, where the redox state is critical for the function of many transcription factors.
Finally, the interaction of Bud32 with Ykr038/Kae1, a putative protease essential to cell life, is of particular interest as in some archaebacteria species the sequence homologous to Bud32 and Ykr038 are fused in a polypeptide encoded by a single gene, supporting the view that functional interactions between members of the Bud32 and Ykr038 families play a crucial role which is highly conserved along the evolutionary scale.
